Dr. David Platt and Pro-Pharmaceuticals to Vigorously Contest Counterclaims Asserted by GlycoGenesys.
Business Wire › February 25, 2004
Linked as:
Extract
Dr. David Platt and Pro-Pharmaceuticals to Vigorously Contest Counterclaims Asserted by GlycoGenesys.
Business Editors/Health/Medical Writers
BIOWIRE2K NEWTON, Mass.--(BUSINESS WIRE)--Feb. 25, 2004 Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel therapeutics for cancer treatment, ...See the full content of this document
Sponsored links
